|
|
|
Insider
Information: |
Spiegelman Daniel K |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
155,668 |
|
Indirect Shares
|
6,673 |
|
|
Direct
Value |
$5,004,686 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
162,341 |
|
|
Total
Value |
$5,004,686 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
CV Therapeutics Inc |
CVTX |
SVP, CFO |
2009-04-09 |
67,489 |
2009-04-09 |
6,673 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2009-12-04 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2019-04-30 |
47,686 |
2012-05-29 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
Director |
2023-06-02 |
40,493 |
2020-05-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
180 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CVTX |
CV Therapeutics Inc |
Senior Vice President and CFO |
|
2004-01-13 |
4 |
A |
$14.67 |
$10,000 |
I/I |
682 |
1,524 |
|
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2005-01-24 |
4 |
A |
$19.31 |
$6,488 |
I/I |
336 |
1,860 |
|
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2007-11-09 |
4 |
A |
$10.12 |
$126,500 |
D/D |
12,500 |
18,488 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2007-12-05 |
4 |
A |
$9.50 |
$47,500 |
D/D |
5,000 |
19,020 |
0 |
- |
|
CVTX |
CV Therapeutics Inc |
SVP, CFO |
|
2007-12-11 |
4 |
A |
$9.40 |
$47,000 |
D/D |
5,000 |
14,233 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2009-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,185 |
6,185 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2010-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,086 |
14,271 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2011-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,538 |
18,809 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2012-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
33,000 |
0 |
- |
|
CASC |
Cascadian Therapeutics, I... |
Director |
|
2012-06-07 |
4 |
A |
$3.67 |
$29,999 |
D/D |
8,174 |
25,492 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-03-18 |
4 |
A |
$61.38 |
$860 |
D/D |
14 |
68,690 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-03-20 |
4 |
A |
$61.43 |
$556 |
D/D |
9 |
68,699 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
13,200 |
46,200 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-06-19 |
4 |
A |
$58.57 |
$1,057 |
D/D |
18 |
68,717 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-09-10 |
4 |
A |
$70.06 |
$1,053 |
D/D |
15 |
68,732 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-10-04 |
4 |
A |
$74.07 |
$370 |
D/D |
5 |
68,737 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-10-07 |
4 |
A |
$74.84 |
$449 |
D/D |
6 |
68,743 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-10-30 |
4 |
A |
$65.75 |
$595 |
D/D |
9 |
68,752 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-10-31 |
5 |
A |
$55.44 |
$4,047 |
D/D |
73 |
38,023 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2013-11-20 |
4 |
A |
$65.89 |
$527 |
D/D |
8 |
68,760 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
64,273 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-04-30 |
4 |
A |
$49.50 |
$4,653 |
D/D |
94 |
64,367 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
13,800 |
73,134 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2014-08-06 |
4 |
A |
$62.17 |
$870 |
D/D |
14 |
68,751 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2015-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
79,278 |
0 |
- |
|
180 Records found
|
|
Page 1 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|